CAS No. : | 230955-75-6 | MDL No. : | MFCD08460968 |
Formula : | C11H9ClN2O3 | Boiling Point : | No data available |
Linear Structure Formula : | - | InChI Key : | VWBHHSJRPOSFGG-UHFFFAOYSA-N |
M.W : | 252.65 | Pubchem ID : | 22022160 |
Synonyms : |
Num. heavy atoms : | 17 |
Num. arom. heavy atoms : | 10 |
Fraction Csp3 : | 0.18 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 62.54 |
TPSA : | 61.31 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.26 cm/s |
Log Po/w (iLOGP) : | 2.23 |
Log Po/w (XLOGP3) : | 2.22 |
Log Po/w (WLOGP) : | 2.22 |
Log Po/w (MLOGP) : | 1.44 |
Log Po/w (SILICOS-IT) : | 2.42 |
Consensus Log Po/w : | 2.11 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.04 |
Solubility : | 0.229 mg/ml ; 0.000907 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.14 |
Solubility : | 0.182 mg/ml ; 0.00072 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.15 |
Solubility : | 0.0178 mg/ml ; 0.0000703 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 1.91 |
Signal Word: | Warning | Class: | |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | |
GHS Pictogram: | ![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96.3% | With sulfuryl dichloride; In acetonitrile; at 65℃;Inert atmosphere; | Under nitrogen atmosphere, 14g, D301 macroporous weakly basic styrene anion exchange resin, 6-acetoxy-7-Methoxy-3,4-dihydroquinazolin-4-one (23.4g, 100mol), sulfuryl chloride (20.3g, 150mmol) in 100ml acetonitrile. The catalytic reaction temperature was 65C. Then the reaction was quenched with ice-water, extracted with methylene chloride, concentrated under reduced pressure to give 6-acetoxy-4-chloro-7-methoxy-quinazoline 24.3g, yield 96.3%, purity 98.81%. |
96.57% | With 1,4-diaza-bicyclo[2.2.2]octane; thionyl chloride; In toluene; at 70℃; for 5h;Inert atmosphere; | 10 g (42.70 mmol) of the starting material <strong>[179688-53-0]3,4-dihydro-7-methoxy-4-oxoquinazolin-6-ol acetate</strong>,Dichlorosulfoxide5.60 g (46.95 mmol), toluene (200 ml), macroporous resin 0.1 g and triethylenediamine0.12 g was separately added to a 500 ml single-mouth bottle, and the temperature was raised to 70 C under nitrogen protection for 5 hours.Water (200 ml) was added, a small amount of solid was precipitated, filtered, and the aqueous phase was extracted with ethyl acetate (50ml × 3).The organic phases were combined, dried, filtered and evaporated.The solid was recrystallized from ethyl acetate and petroleum ether (V ethyl acetate: V petroleum ether = 1:10).10.6 g of a white powdery solid was obtained, the yield was 96.57%, and the purity was 99.08% (HPLC detection). |
94% | With trichlorophosphate; at 80 - 100℃; for 1h; | A suspension of compound 4 (1.80 g, 7.69 mmol) and N,N-diethylaniline (1.7 mL) in POCl3 (9 mL) was immersed in a preheated oil bath (100 C) and stirred at 100 C for 30 min. The reaction mixture was cooled to 80 C and stirred for further 30 min. Excess POCl3 was removed under vacuum, and the residual was triturated with toluene three times. Ice-water was added, and the resultant precipitate was filtered, washed with cooled water and dried under vacuum to afford 5 (1.83 g, 94%) as a gray solid, which was used for next step. |
94% | With thionyl chloride; In N,N-dimethyl-formamide; for 24h;Reflux; | 3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-ol acetate (4 g, 17.1 mmol)Placed in 100mL conical flask,After adding 40 mL of thionyl chloride and 1 drop of DMF at room temperature,Heated to reflux for 24 hours;Most of the thionyl chloride was distilled off, ice water was added, filtered,After drying, 4-chloro-7-methoxyquinazolin-6-ol acetate (4.07 g) was obtained in a yield of 94% |
93.7% | With thionyl chloride; In N,N-dimethyl-formamide; acetonitrile; at 80℃;Cooling with ice; | Add 1.0 mol/L thionyl chloride (205 mL) dropwise to the mixture of Intermediate 1 (12.0 g, 51 mmol) and acetonitrile (100 mL) under ice bath conditions,Subsequently, 0.5 mL of N,N-dimethylformamide was added, the dripping was completed, and the mixture was refluxed at 80 C., and TLC detected the completion of the reaction.The solvent was evaporated under reduced pressure, the residue was poured into 150 mL of water, and saturated sodium bicarbonate aqueous solution was slowly added dropwise to the residue under ice bath.Adjust the pH to 8.0-9.0, filter, wash the filter cake with water, and dry the filter cake under vacuum to obtain Intermediate 2 (12.1 g, yield 93.7%), which can be used in the next reaction without further purification. |
90.2% | With thionyl chloride; In N,N-dimethyl-formamide; at 90℃; for 2h; | Adding (7-methoxy-4-oxo-3,4-dihydroquinazoline)-6- obtained in Step 1 to a 50 mL round bottom flask Base-acetate (1 g), thionyl chloride (15 mL), N,N-dimethylformamide (75 μL) was reacted at 90 C for 2 h. The reaction was complete by TLC. After the reaction system was cooled to room temperature, the system was steamed under reduced pressure, and after spin-drying, 30 mL of ice water was added to a round bottom flask under ice-water bath, and stirred vigorously. The suspension was then transferred to a separatory funnel and extracted with 60 mL of chloroform and 30 mL of saturated aqueous sodium chloride. After the obtained chloroform solution is dried, sodium sulfate is removed by filtration, and the chloroform solution is evaporated under reduced pressure to give 4-chloro-7-methoxyquinazoline-6-yl acetate as a white solid. The yield was 90.2%. |
90% | With thionyl chloride; N,N-dimethyl-formamide; at 85℃; for 5h; | 6-acetoxy-7-methoxy-4-oxo-3,4-dihydroquinazoline(3.0g, 12.87mmol) dissolved in thionyl chloride (45 mL, 64.36 mmo), DMF (5 mL) was added to help dissolve. The mixture was heated to reflux at 85 C for 5 hours. Cool to room temperature, remove the solvent and thionyl chloride under reduced pressure, and pour the residue into ice water (50 mL).Filtration, washing the solid with petroleum ether (50 mL) and drying under reduced pressure.Obtained a white solid (2.9 g, 90%).Go directly to the next step. |
86.1% | With thionyl chloride; In N,N-dimethyl-formamide; for 2h;Reflux; | 6-carbethoxy-7-methoxy-4 (3H) -quinazolinone (5 g, 21.4 mmol) was added to the reactor,Thionyl chloride, 0.5 mL of N, N-dimethylformamide was added, and the mixture was heated to reflux for 2 hours. After completion of the reaction, thionyl chloride was removed by rotary evaporation, and saturated sodium hydrogencarbonate solution was added to the residue under ice-water bath and stirred until no gas evolved. The mixture was extracted with dichloromethane and dried over anhydrous sodium sulfate. The desiccant was removed by filtration and the solvent was removed by rotary evaporation to give 5.23 g of 4-chloro-6-ethoxycarbonyl-7-methoxy-4 (3H) -quinazoline as a pale yellow solid in a yield of 86.1%. |
85.4% | With trichlorophosphate; In toluene; for 6h;Reflux; | In a 100 ml reaction flask by adding 6-acetoxy-7- [...] -4-one (4g, 0.017mol), phosphorus oxychloride (24 ml), toluene (34 ml), slow heating, heating to reflux, the reaction 6h. After the reaction is ended, revolving off a solvent and phosphorus oxychloride, adding proper amount of crushed ice, intense stirring, chloroform extraction (3×25 ml), combined with the phase, using saturated NaHCO 3 washing (3×25 ml), the resulting the resulting solid with toluene is recrystallized to get white solid, yield 85.4%. |
84% | With oxalyl dichloride; for 4h;Reflux; | 200 g (0.85 mol) of the compound of the formula I was added to a 2 L three-necked flask, 1.5 L of oxalyl chloride was added, and the mixture was heated to reflux for 4 hours, and the reaction was monitored by HPLC. The haloyl chloride was evaporated, and 0.5 L of dichloromethane was added to carry out the residual oxalyl chloride to give a crude VII. Further, 0.5 L of dichloromethane was added to dissolve the crude VII, washed once with a saturated aqueous solution of sodium hydrogencarbonate (400 mL) and brine (400 mL), and the organic phase was dried over anhydrous sodium sulfate. Methane, the remaining liquid is poured into about 2LThe crystals were stirred and stirred in n-hexane. Filtration, collection of solid, drying at 50 C to give a pale yellow compound of formula VII 180 g, a molar yield of 84%, purity 98%. |
77% | With thionyl chloride; In N,N-dimethyl-formamide; for 3h;Reflux; | A suspension of <strong>[179688-53-0]7-methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate</strong> (1) (2.34 g) in SOCl2 (30 mL) and DMF (0.5 mL) was refluxed for 3 h. After that, the mixture was concentrated under reduced pressure to give 4-chloro-7-methoxyquinazolin-6-yl acetate (2). Yellow powder, yield: 77%. 1H NMR (300 MHz; d6-DMSO): 2.08 (s, 3H); 3.73 (s, 3H); 7.55 (s, 1H); 7.50 (s, 1H); 9.44 (s, 1H). MS (ESI+) m/z 253.6 (M + H)+. |
65% | With trichlorophosphate; for 3h;Heating / reflux; | A mixture of <strong>[179688-53-0]3,4-dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate</strong> (0104) (2.0 g,8.5 mmol) and phosphoryl trichloride (20 ml) was stirred and heated to reflux for 3 hours. When a clear solution was obtained, the excessive phosphoryl trichloride was removed under reduced pressure. The residue was dissolved in dichloromethane (50ml) and the organic layer was washed with aqueous NaHCO3 solution (20ml><2) and brine (2OmIx 1) and dried over MgSO4, filtered and evaporated to give the title product 0105 as a yellow solid (IAg, 65%): LCMS: m/z 249[M+1]+; 1H NMR(CDCl3.) δ 2.40 (s, 3H), 4.03 (s, 3H), 7.44 (s, IH), 7.90 (s, IH), 8.95 (bs, IH). |
65% | With trichlorophosphate; for 3h;Heating / reflux; | A mixture of <strong>[179688-53-0]3,4-dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate</strong> (0104) (2.0 g,8.5 mmol) and phosphoryl trichloride (20 ml) was stirred and heated to reflux for 3 hours. When a clear solution was obtained, the excessive phosphoryl trichloride was removed under reduced pressure. The residue was dissolved in dichloromethane (50ml) and the organic layer was washed with aqueous NaHCO3 solution (20ml><2) and brine (2OmIx 1) and dried over MgSO4, filtered and evaporated to give the title product 0105 as a yellow solid (IAg, 65%): LCMS: m/z 249[M+1]+; 1H NMR(CDCl3.) δ 2.40 (s, 3H), 4.03 (s, 3H), 7.44 (s, IH), 7.90 (s, IH), 8.95 (bs, IH). |
65% | With trichlorophosphate; for 3h;Heating / reflux; | Step 1h. 4-Chloro-7-methoxyquinazolin-6-yl acetate (Compound 110) A mixture of compound 109 (2.0 g, 8.5 mmol) and phosphoryl trichloride (20 mL) was stirred and heated to reflux for 3 hours. When a clear solution was obtained, the excessive phosphoryl trichloride was removed under reduced pressure. The residue was dissolved in dichloromethane (50 mL) and the organic layer was washed with aqueous NaHCO3 solution (20 mL*2) and brine (20 mL*1) and dried over MgSO4, filtered and evaporated to give the title product 110 as a yellow solid (1.4 g, 65%): LCMS: 253 [M+1]+. |
65% | With trichlorophosphate; In dichloromethane; for 3h;Heating / reflux; | Step 1d. 4-Chloro-7-methoxyquinazolin-6-yl acetate (Compound 0105) A mixture of <strong>[179688-53-0]3,4-dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate</strong> (0104) (2.0 g, 8.5 mmol) and phosphoryl trichloride (20 ml) was stirred and heated to reflux for 3 hours. When a clear solution was obtained, the excessive phosphoryl trichloride was removed under reduced pressure. The residue was dissolved in dichloromethane (50 ml) and the organic layer was washed with aqueous NaHCO3 solution (20 ml*2) and brine (20 ml*1) and dried over MgSO4, filtered and evaporated to give the title product 0105 as a yellow solid (1.4 g, 65%): LCMS: m/z 249 [M+1]+; 1H NMR (CDC3.) δ 2.40 (s, 3H), 4.03 (s, 3H), 7.44 (s, 1H), 7.90 (s, 1H), 8.95 (bs, 1H). |
65% | Step 1d. 4-Chloro-7-methoxyquinazolin-6-yl Acetate (Compound 0105); A mixture of <strong>[179688-53-0]3,4-dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate</strong> (0104) (2.0 g, 8.5 mmol) and phosphoryl trichloride (20 ml) was stirred and heated to reflux for 3 hours. When a clear solution was obtained, the excessive phosphoryl trichloride was removed under reduced pressure. The residue was dissolved in dichloromethane (50 ml) and the organic layer was washed with aqueous NaHCO3 solution (20 ml×2) and brine (20 ml×1) and dried over MgSO4, filtered and evaporated to give the title product 0105 as a yellow solid (1.4 g, 65%): LCMS: m/z 249[M+1]+; 1H NMR (CDC3) δ 2.40 (s, 3H), 4.03 (s, 3H), 7.44 (s, 1H), 7.90 (s, 1H), 8.95 (bs, 1H). | |
60% | With thionyl chloride; N,N-dimethyl-formamide; at 100℃; for 3h;Inert atmosphere; | The 1000 ml thionyl chloride (SOCl 2) placed in 2000 ml of the four protection of nitrogen in neck circle bottom flask, slowly dropping 10mLDMF catalytic (20 minutes drops end), adding 100g7-methoxy-4-oxo -3,4-dihydric quinazoline-6-yl ester, 100 C lower stirring 3 hours. Reaction fluid ice-bath cooling to room temperature, concentrated under reduced pressure to dry with 1000 ml of methylene chloride is dissolved, into 1000 ml ice water. Dichloromethane is used for extraction mixed solution 2 time, combined with the organic layer, washing with saturated sodium chloride aqueous solution 3 times. Separating the organic layer in the 250 ml triangular flask adding anhydrous sodium sulfate for drying 6 hours, vacuum filtration. Filtrate concentrated to dry, by ether washing, 65g (yield 60%) of compound 1, as a pale yellow powder. |
60% | With thionyl chloride; N,N-dimethyl-formamide; at 100℃; for 3h;Inert atmosphere; | The 1000mL thionyl chloride (of SOCl2) placed in the nitrogen 2000mL four-neck round bottom flask, was slowly added dropwise 10mLDMF catalytic (20 minutes after the dripping) was added 4-oxo-3,4-methoxy 100g7- dihydro-quinazolin-6-yl acetate, followed by stirring at 100 3 hours. The reaction solution was ice-cooled to room temperature, concentrated under reduced pressure was dissolved in 1000mL of methylene chloride to dryness, poured into ice-water 1000mL. Mixture was extracted twice with methylene chloride, the organic layers combined, washed with saturated aqueous sodium chloride solution three times. The separated organic layer was dried over anhydrous sodium sulfate was added 6 hours in a 250mL Erlenmeyer flask, filtered under reduced pressure. The filtrate was concentrated under reduced pressure to dryness, washed with diethyl ether to give 65g (60% yield) of Compound 1 as a pale yellow powder |
60% | With thionyl chloride; N,N-dimethyl-formamide; at 100℃; for 3h;Inert atmosphere; | The 1000mL thionyl chloride (of SOCl2) placed2000mL of nitrogen four-neck round bottom flask was slowly dropped 10mLDMF catalysis (20 minutes drops End), was added 100g7-methoxy-4-oxo-3,4-dihydro-quinazolin-6-yl acetate, followed by stirring at 100 3 hours. The reaction solution was cooled to ice bath temperature, concentrated under reduced pressure was dissolved in 1000mL of methylene chloride to dryness, poured into ice water 1000mL. Mixture was extracted twice with methylene chloride, the organic layers combined, washed with saturated aqueous sodium chloride solution three times. The separated organic layer was dried over anhydrous sodium sulfate was added 6 hours in a 250mL Erlenmeyer flask, filtered under reduced pressure. The filtrate was concentrated under reduced pressure to dryness, washed with diethyl ether to give 65g (60% yield) of Compound 1 as a pale yellow powder. |
60% | With thionyl chloride; In N,N-dimethyl-formamide; at 100℃; for 3h;Inert atmosphere; | The 1000mL thionyl chloride (of SOCl2) Was placed in a nitrogen 2000mL four-neck round bottom flask, was slowly added dropwise (2ml / min) 10mLDMF catalyzed 100g7- was added 4-oxo-3,4-dihydro-methoxy-quinazolin-6-yl acetate, 100 stirred for 3 hours.The reaction solution was ice-cooled to room temperature, concentrated under reduced pressure was dissolved in 1000mL of methylene chloride to dryness, poured into ice-water 1000mL.Mixture was extracted twice with methylene chloride, the organic layers combined, washed with saturated aqueous sodium chloride solution three times.The separated organic layer was dried over anhydrous sodium sulfate was added in a 250mL flask and dried for 6 hours and filtered under reduced pressure.The filtrate was concentrated under reduced pressure to dryness, washed with diethyl ether to give 65g (60% yield) of Compound 1 as a pale yellow powder. |
60% | With thionyl chloride; In N,N-dimethyl-formamide; at 100℃; for 3h;Inert atmosphere; | 1000 mL of thionyl chloride (SOCl2) was placed in a 2000 mL nitrogen blanketed four-necked round bottom flask and 10 mL of DMF was slowly added dropwise over 20 minutes. 100 g<strong>[179688-53-0]7-methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate</strong> was stirred at 100 C for 3 hours. The reaction solution was ice-cooled to room temperature, concentrated under reduced pressure to dryness, dissolved in 1000 mL of methylene chloride, and poured into 1000 mL of ice water. The mixture was extracted twice with dichloromethane, and the combined organic layers were washed three times with a saturated aqueous sodium chloride solution. The organic layer was separated, dried over anhydrous sodium sulfate for 6 hours in a 250 mL Erlenmeyer flask, and filtered under reduced pressure. The filtrate was concentrated to dryness under reduced pressure and washed with diethyl ether to give 65 g (60% yield) of Compound 1 as a pale yellow powder. |
48% | With thionyl chloride; N,N-dimethyl-formamide; for 2h;Inert atmosphere; Reflux; | Under argon, quinazolinone 9 (1.79 g, 7.64 mmol) was dissolved in thionyl chloride (14.5 mL) and DMF (73.0 μL) was added. The mixture was stirred 2 h at reflux then toluene was added and removed under vacuum. The product was purified by flash column chromatography using hexane/EtOAc (85:15) to afford 10 as a cream solid (923 mg, 48%). Mp: 157-159 C; IR (ATR, ZnSe): ν (cm-1) 2986, 1755, 1619, 1559, 1432, 1350, 1203, 1145, 1015, 912, 809, 703; 1H NMR (500 MHz, CDCl3): δ (ppm) 8.95 (s, 1H), 7.90 (s, 1H), 7.43 (s, 1H), 4.02 (s, 3H), 2.40 (s, 3H). 13C NMR (126 MHz, CDCl3): δ (ppm) 168.7, 161.0, 157.4, 154.3, 151.7, 142.5, 119.0, 118.6, 108.3, 56.8, 20.7; HRMS-ESI calcd for C11H10ClN2O3 [M+H]+ 253.0375 found 253.0381. |
With thionyl chloride; N,N-dimethyl-formamide; at 85℃; for 1.5h;Product distribution / selectivity; | Step 6. Product step 5 (8.54 mmol) was converted into 4-chloro-7-hydroxy-6-methoxyquinazoline or 4-chloro-6-hydroxy-7-methoxyquinazoline, respectively, (58-95%) by reacting them with thionyl chloride (12 mL) and DMF (0.3 mL) at 85 C for 1.5 h. Excess thionyl chloride was removed by distillation. Traces of thionyl chloride were removed by aceotropic distillation wit toluene (two times). Alternatively the products step 5 can be converted into the chlorides by reacting them with a mixture of POCl3 and PCl5. The acetyl groups were removed by hydrolysis with ammonium hydroxide (5 mL, 28-30 wt%) in dioxane / water (100 mL / 20 mL) at 0 C to r.t. | |
With thionyl chloride; In DMF (N,N-dimethyl-formamide); at 90℃; for 4h; | The 4-amino-7-methoxy-6-(3-piperidinopropoxy)quinazoline used as a starting material was prepared as follows :- A mixture of 6-acetoxy-7-methoxyquinazolin-4-one (International Patent Application WO 96/15118, Example 39 thereof; 15 g), thionyl chloride (215 ml) and DMF (4.3 ml) was stirred and heated to 90 C. for 4 hours. The mixture was cooled to ambient temperature and the thionyl chloride was evaporated. The material so obtained was dissolved in toluene and the solution was washed with a saturated aqueous sodium bicarbonate solution. The organic No. solution was dried over magnesium sulphate and evaporated. There was thus obtained 6-acetoxy-4-chloro-7-methoxyquinazoline (14.8 g) which was used without further purification. A mixture of a portion (5 g) of the material so obtained, diphenylmethyleneamine (3.75 g), caesium carbonate (25.67 g) and xylene (200 ml) was stirred at ambient temperature for 30-minutes. Racemic 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (1.227 g) and palladium diacetate (0.221 g) were added and the mixture was stirred and heated to 135 C. for 16 hours. The mixture was cooled to ambient temperature and diethyl ether (600 ml) was No. added. The mixture was filtered and the filtrate was evaporated. There was thus obtained N-diphenylmethylene-6-acetoxy-7-methoxyquinazolin-4-amine (7.12 g); Mass Spectrum: M + H+ 398. A mixture of a portion (3.09 g) of the material so obtained, concentrated ammonium hydroxide solution (0.88 g/ml approximately 14M; 60 ml) and methanol (120 ml) was stirred at ambient temperature for 16 hours. The mixture was evaporated. Toluene (200 ml) was added and the mixture was evaporated again. The residue was triturated under diethyl ether (50 ml). There was thus obtained N-diphenylmethylene-6-hydroxy-7-methoxyquinazolin-4-amine (0.93 8 g); Mass Spectrum: No. M + H+ 356. A mixture of the material so obtained, 3-piperidinopropyl chloride (0.55 g), potassium carbonate (1.46 g) and DMF (50 ml) was stirred and heated to 65 C. for 16 hours. The resultant mixture was evaporated and the residue was partitioned between ethyl acetate and water. The organic solution was washed with a saturated aqueous sodium chloride solution, dried over magnesium sulphate and evaporated The residue was purified by column No. chromatography on silica using increasingly polar mixtures of methylene chloride and methanol as eluent. There was thus obtained N-dphenylmethylene-6-(3-piperidinopropoxy)-7-methoxyquinazolin-4-amine (0.277 g); NMR Spectrum: (DMSOd6) 1.3 (br s, 2H), 1.42 (br s, 4H), 1.88 (t, 2H), 2.28 (br s, 4H), 2.38 (t, 2H), 3.92 (s, 3H), 4.07 (t, 2H), 7.0 (s, 1H), 7.23 (s, 1H), 7.2-7.65 (br m, 10H), 8.62 (s, 1H); Mass Spectrum: M + H+ 481. A mixture of the material so obtained, 3N aqueous hydrochloric acid solution (2 ml) and THF (14 ml) was stirred at ambient temperature for 3 hours. The mixture was evaporated and the residue was treated with a 2N aqueous sodium hydroxide solution (10 ml). The resultant precipitate was isolated, washed with water (10 ml) and dried under vacuum. There was thus obtained 4-amino-7-methoxy-6-(3-piperidinopropoxy)quinazoline (0.202 g); NMR Spectrum: No. (DMSOd6) 1.36 (br s, 2H), 1.47(br s, 4H), 1.93 (t, 2H), 2.25-2.43 (br m, 6H), 3.88 (s, 3H), 4.05 (t, 2H), 7.04 (s, 1H), 7.35 (br s, 2H), 7.55 (s, 1H), 8.23 (s, 1H); Mass Spectrum: M + H+ 317. | |
With thionyl chloride; | Example 30 4-[3-chloro-4-(3-fluorobenzyloxy)-phenylamino]-6-(3-(4-morph olino)propoxy)-7-methoxy-quinazoline 6,7-dimethoxy-quinazolone was reacted with methanesulfonic acid and L-methionine under reflux for 2 h, and then the mixture was poured into ice water to deposit a solid, which is 6-hydroxy-7-methoxy-quinazolone intermediate. After the hydroxyl group therein was protected by acylation, the intermediate was treated with SOCl2 to obtain 4-chloro-6-acetoxy-7-methoxy-quinazoline. | |
N,N-dimethyl-formamide; In thionyl chloride; | Step 3 4-Chloro-7-methoxyquinazolin-6-yl acetate: A catalytic amount of N,N-dimethylformamide was added to a solution of <strong>[179688-53-0]7-methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate</strong> (2.7 g, 11.53 mmol, 1.00 equiv) in thionyl chloride (35 mL). The resulting solution was stirred at about 83 C. for about 1 hour, and then was cooled to ambient temperature and thionyl chloride was removed by evaporation. The title product was isolated as a hydrochloride salt (5.0 g, (crude)). | |
A mixture of <strong>[179688-53-0]7-methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate</strong> (8.7 g, 0.037 mol), thionyl chloride (120 ml, 1.65mol) and DMF(I ml) was stirred and heated to 55 0C for 6 hours. The mixture was cooled to room temperature and thionyl chloride was evaporated. The solid was dissolved in chloroform and the solution was washed with sodium bicarbonate and brine, the chloroform was evaporated under reduced pressure to give 7.9 g of a gray product. MS (ESI) m/z: 253 (M+l). | ||
With thionyl chloride; In N,N-dimethyl-formamide; at 70℃; for 3h; | A suspension of <strong>[179688-53-0]7-methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate</strong> (2.00 g), DMF (0.20 mL) and thionyl chloride (30 mL) was stirred at 70 C for 3 h. The mixture was concentrated in vacuo, and the residue was used for the next step without further purification. | |
With thionyl chloride; In N,N-dimethyl-formamide; at 70℃; for 3h; | A suspension of <strong>[179688-53-0]7-methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate</strong> (2.00 g), DMF (0.20 mL) and thionyl chloride (30 mL) was stirred at 70 C. for 3 h. The mixture was concentrated in vacuo, and the residue was used for the next step without further purification. | |
With triethylamine; trichlorophosphate; In toluene; at 80℃; for 4h; | Amixture of 1 (1.0 g, 4.27 mmol), triethylamine (1.2 mL, 8.66 mmol) and phosphorus oxychloride (1.2 mL, 13.11 mmol) in toluene (15 mL) was heated to 80 C for 4 h, which directly to the next step reaction without purification. | |
With triethylamine; trichlorophosphate; In acetonitrile; at 80℃; | 10g of compound GG4 placed 40ml of acetonitrile, followed by adding 8.3 g of phosphorus oxychloride, 5.4 g of triethylamine, and the reaction was heated to 80 C, the reaction was complete after TLC monitoring | |
With thionyl chloride; for 2.5h;Reflux; | 20 ml of thionyl chloride was added to the intermediate M-1 (2.34 g, 10 mmol)Reflux for 2.5 hours. Evaporated under reduced pressureThionyl chloride,Dichloromethane extraction,Dried over anhydrous sodium sulfate,The crude product obtained by spin-removing the solvent was intermediate M-2 (2.22 g, 88%). | |
With thionyl chloride; N,N-dimethyl-formamide; at 85℃; for 1.5h;Product distribution / selectivity; | Step 6. Product step 5 (8.54 mmol) was converted into 4-chloro-7-hydroxy-6-methoxyquinazoline or 4-chloro-6-hydroxy-7-methoxyquinazoline, respectively, (58-95%) by reacting them with thionyl chloride (12 mL) and DMF (0.3 mL) at 85 C. for 1.5 h. Excess thionyl chloride was removed by distillation. Traces of thionyl chloride were removed by aceotropic distillation wit toluene (two times). Alternatively the products step 5 can be converted into the chlorides by reacting them with a mixture of POCl3 and PCl5. The acetyl groups were removed by hydrolysis with ammonium hydroxide (5 mL, 28-30 wt %) in dioxane/water (100 mL/20 mL) at 0 C. to r.t. | |
With phosphorus pentachloride; trichlorophosphate;Product distribution / selectivity; | Step 6. Product step 5 (8.54 mmol) was converted into 4-chloro-7-hydroxy-6-methoxyquinazoline or 4-chloro-6-hydroxy-7-methoxyquinazoline, respectively, (58-95%) by reacting them with thionyl chloride (12 mL) and DMF (0.3 mL) at 85 C. for 1.5 h. Excess thionyl chloride was removed by distillation. Traces of thionyl chloride were removed by aceotropic distillation wit toluene (two times). Alternatively the products step 5 can be converted into the chlorides by reacting them with a mixture of POCl3 and PCl5. The acetyl groups were removed by hydrolysis with ammonium hydroxide (5 mL, 28-30 wt %) in dioxane/water (100 mL/20 mL) at 0 C. to r.t. | |
25 g | With N-ethyl-N,N-diisopropylamine; trichlorophosphate; In toluene; at 70 - 100℃; for 3.5h; | 23.4 g of <strong>[179688-53-0]3,4-dihydro-7-methoxy-4-oxoquinazolin-6-ol acetate</strong>,39g DIEA, 280mL of toluene addedIn a 1000 mL reaction bottle,Warm up to 70 C, heat stirring for 0.5 h,Add 45g of phosphorus oxychloride,Then heat up to 90 ~ 100 C,Stirring at this temperature for 3 h,After the TLC reaction was completed, the mixture was cooled to room temperature, concentrated to dryness under reduced pressure, and finally 50 mL of ethanol was added and stirred at room temperature for 0.5 h.Filtering,Then drying at 40 to 50 C to obtain 25 g of compound 2; |
21.5 g | With thionyl chloride; In N,N-dimethyl-formamide; at 80℃; for 6h; | 6-Hydroxy-7-methoxy-4-ketoquinazoline (20 g, 0.11 mol, ie compound B1), acetic anhydride (150 mL, 1.6 mol) and pyridine (20 mL, 0.25 mol) were sequentially added to a 500 mL circle In the bottom flask, after heating to 100 C for 1 h, add 4-dimethylaminopyridine (0.9 g, 0.0073πο 1), continue the reaction for 5 h, stop the reaction, evaporate acetic anhydride under reduced pressure, and add cold to the reaction solution. The saturated sodium carbonate solution (500 mL) was stirred, suction filtered, and the filter cake was transferred to a round bottom flask and stirred with a large amount of ice water, suction filtered, and the filter cake was washed with distilled water until ΡΗ = 7, and dried to give a yellow-white solid ( Compound B2). This was sequentially added to a 500 mL three-neck round bottom flask with thionyl chloride (190 mL, 2.0 mol), and the mixture was heated to 80 C for reflux for 20 min, and N,N-dimethylformamide was slowly added from a constant pressure dropping funnel. (4.4 mL, 0.52 eq) was added dropwise to the reaction mixture. After reacting for 6 h, the reaction was stopped, cooled, and the thionyl chloride was recovered under reduced pressure. Toluene was added with stirring, and toluene was added under reduced pressure. Toluene (250 mL) was added to the reaction mixture and stirred for about 1 h, dichloromethane (120 mL*2) Extract and separate the organic layer,Wash with water (80 mL * 2), dry over anhydrous sodium sulfate, and dilute dichloromethane under reduced pressure.Obtained 21.5 g of an off-white solid, yield: 81.9%. |
With N-ethyl-N,N-diisopropylamine; trichlorophosphate; In toluene; at 75℃; for 3h; | At 75 C, phosphorus oxychloride (5 mL) was added dropwise to a solution of compound 6 (5 g) and DIPEA (4.13 ml) in toluene (45 ml) over 20 min. After the addition was completed, the reaction mixture was stirred at the current temperature. 3hrs. After the reaction is completed, it is directly put into the next step | |
33 g | 35g3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-ol acetate, 55g DIEA, 320mL toluene were added to a 1000mL reaction flask, heated to 70C, kept warm and stirred for 0.5h,Then add 65g of phosphorus oxychloride, then increase the temperature to 95C, stir and react at this temperature for 3h;After TLC detects that the reaction is complete, cool to room temperature, concentrate under reduced pressure to dryness, and finally add 60 mL of ethanol, and stir at room temperature for 0.5 h.Suction filtration and drying at 45C to obtain 33 g of compound 2; | |
With N-ethyl-N,N-diisopropylamine; trichlorophosphate; In toluene; at 75℃; for 3h;Inert atmosphere; | (1) Take a 250mL three-necked flask, add PZT-1 (10g, 42.7mmol), toluene (85mL) and DIEA (6.46g, 49.9mmol) to it, stir well and add phosphorus oxychloride (16.43g, 107.2mmol), the reaction solution was heated to an internal temperature of 75C under the protection of nitrogen, A large amount of white smoke was generated. The mixed solution was stirred and reacted at the same temperature for 3 hours. The insoluble matter gradually dissolved. Add 2-fluoro-3,4-dichloroaniline (8.45g, 46.9mmol) to the reaction solution at the same internal temperature. Toluene (45mL) solution. After adding the reaction solution, stir and react at 75C for 3 hours. A large amount of solid insoluble matter gradually precipitated. Cool the reaction solution to room temperature. Add ice-water mixture (200g) and ethyl acetate (200mL) to it, adjust the pH of the mixture to about 8 with solid sodium bicarbonate under rapid stirring, there are a lot of solid insolubles, filter with suction, wash the filter cake with water, and then Wash with a small amount of ethyl acetate (30 mL), take out the filter cake and pull dry the solvent to obtain white powder PZT-3 (11.56 g) with a yield of 68.5%. | |
With N-ethyl-N,N-diisopropylamine; trichlorophosphate; In toluene; at 75℃; for 3.33333h; | 7-methoxy-4-oxo-3,4-dihydroquinazolin-yl acetate (100 g) was added to toluene (850 ml) and A,A-diisopropylethylamine (82.5 ml). Phosphorusoxy chloride (100 ml) was added thereto over 20 minutes at 75C, followed by stirring for 3 hours. Toluene (450 ml) and 3,4-dichloro-2-fluoroaniline (84.6 g) were added to the resulting mixture, followed by stirring for 2 hours. Upon completion of the reaction, the resulting mixture was cooled to 25C. The solid thus obtained was filtered under a reduced pressure and washed with toluene (400 ml). Isopropanol (1,000 ml) was added to the solid, which was then stirred for 2 hours. The resulting solid was filtered and washed with isopropanol (400 ml). The solid was dried at 40C in an oven to produce the compound of formula (VI) (143 g, yield: 83%). (0049) U-NMR (DMSO-de, 300 MHz, ppm) 8 8.92 (s, 1H), 8.76 (s, 1H), 7.69-7.57 (m, 3H), 4.01 (s, 3H), 2.38 (s, 3H). (0050) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With hydrogenchloride; In acetonitrile; for 1h;Heating / reflux;Product distribution / selectivity; | The 4- (3-chloro-2-fluoroanilino)-6-hydroxy-7-methoxyquinazoline starting material used above was prepared as follows: 6-Acetoxy-4-chloro-7-methoxyquinazoline (Example 25-5 in W001/66099 ; 10. 0g, 39.6 mmole) was suspended in acetonitrile (400 ml) and 3-chloro-2-fluoroaniline (6. 05g, 41. 6 mmole) and hydrogen chloride (4. 0M solution in 1,4-dioxane) (10.4 ml, 41.6 mmole) were added. The reaction mixture was refluxed for one hour and then allowed to cool to ambient temperature. The resulting precipitate was filtered off, washed with acetonitrile and diethylether to give a white solid. This solid was added in portions to a stirred 7N methanolic ammonia solution (400 ml). The mixture was stirred for two hours and the precipitate filtered, washed with acetonitrile followed by diethylether and dried under vacuum to give 4- (3-chloro- 2-fluoroanilino) -6-hydroxy-7-methoxyquinazoline as a white solid (12. 1g, 95%) ; lH NMR Spectrum: (DMSOd6) 3.95 (s, 3H) ; 7.18 (s, lH) ; 7.20-7. 25 (m, 1H); 7.39-7. 44 (m, lH) ; 7.47- 7.52 (m, 11-1) ; 7.65 (s, lH) ; 8.31 (s, 1H) ; 9.45 (br. s, lH) ; Mass Spectrum: (M+H) + 320. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
94% | With ammonia; In methanol; at 20℃; for 1.5h; | A suspension of 4-chloro-7-methoxyquinazolin-6-yl acetate (prepared as described in Example 25-5 of WO01/66099, 10.1 g, 40 mmol) in 6N methanolic ammonia (200 ml) was stirred at room temperature for 90 minutes. The solvents were evaporated under vacuum. Water was added and the resulting suspension was filtered. The solid obtained was washed with water, ether and dried under high. vacuum in the presence-of phosphorus pentoxide to GIVE 4-CHLORO-7-METHOXYQUINAZOLIN-6-OL (7.9 G, 94%). NMR SPECTRUM: (DMSOD6) 4.02 (S, 3H), 7.40 (s, 1H), 7.43 (s, 1H), 8. 81 (s, 1H). |
86% | With ammonia; In methanol; at 20℃; for 1.5h;Inert atmosphere; | Under argon, 10 (800?mg, 3.17?mmol) was dissolved in 11.3?mL of NH3 (7?N in CH3OH) and the mixture was stirred 1.5?h?at room temperature. The solvent was removed under vacuum and a trituration with Et2O afforded 11 as a beige solid (574?mg, 86%). Mp: 300?C (dec.); IR (ATR, ZnSe): nu (cm-1) 3019, 1555, 1497, 1465, 1350, 1188, 1157, 974, 858, 700; 1H NMR (400?MHz, DMSO-d6): delta (ppm) 10.78 (s, 1H), 8.81 (s, 1H), 7.43 (s, 1H), 7.40 (s, 1H), 4.01 (s, 3H). 13C NMR (126?MHz, DMSO-d6): delta (ppm) 158.9, 155.3, 155.2, 149.3, 146.4, 120.2, 105.9, 103.9, 56.0; HRMS-ESI calcd for C9H8ClN2O2 [M+H]+ 211.0269 found 211.0257. |
84.6% | With ammonium hydroxide; In methanol; at 20℃; for 3h; | 7-Methoxy-4-hydroxyquinazolin-6-ol acetate (4.68 g, 20 mmol) and DMF (0.4 mL) were added to 25 mL of thionyl chloride and refluxed for 5 hours. The thionyl chloride was distilled off under reduced pressure, and the mixture was steamed with chloroform (10 mL x 3) and toluene (10 mL x 2) The residual thionyl chloride was removed to give 7-methoxy-4-chloroquinazolin-6-ol acetate.Without purification, it was added to concentrated aqueous ammonia (35 mL)In methanol (70 mL) and stirred at room temperature for 3 hours. The filter cake was washed with ether to give 6-hydroxy-7-methoxy 4-chloroquinazoline, 3.61 g as a pale white solid, 84.6% yield. |
78% | With ammonia; In methanol; at 10℃; | The 10g 4- chloro-7-methoxy-quinazolin-6-yl acetate (Compound 1) was placed in a 250mL three-necked roundFlask in an ice bath was added dropwise with stirring 100mL 7Mu NH3 methanol solution, drip completed within 30 minutes. Below 10 C, the reaction was stirred for more than 30min. The reaction solution was filtered under reduced pressure, residue was washed twice with ether, to give 6. 5g (78% yield) of compound 2,As a pale yellow powder. |
78% | With ammonia; In methanol; at 10℃;Cooling with ice; | The 10g4- chloro-7-methoxy-quinazolin-6-yl acetate (Compound 1) was placed in a 250mL three-necked round bottom flask in an ice bath was added dropwise with stirring 100mL7MNH3- methanol solution, more than 30 minutes dropwise. Below 10 , the reaction was stirred for more than 30min. The reaction solution was filtered under reduced pressure, residue was washed with diethyl ether twice to afford 6.5g (78% yield) of Compound 2 as a pale yellow powder. |
78% | With methanol; ammonia; at 10℃; for 1h;Cooling with ice; | The 10g4- chloro-7-methoxy-quinazolin-6-yl acetate (Compound 1) was placed in a 250mL three-necked roundBottom flask in an ice bath was added dropwise with stirring 100mL 7MNH3- methanol solution, drip completed within 30 minutes. 10 Hereinafter, the reaction mixture was stirred for more than 30min. The reaction solution was filtered under reduced pressure, residue was washed twice with ether, to give 6.5g(78% yield) of compound 2 as a pale yellow powder. |
78% | With ammonia; In methanol; at 10℃; for 1h;Cooling with ice; | The 10g4- chloro-7-methoxy-quinazolin-6-yl acetate (Compound 1) was placed in a 250mL three-necked round bottom flask in an ice bath was added dropwise with stirring 100mL7MNH3-Methanol solution within 30 minutes after dropping below 10 , the reaction was stirred for more than 30min.The reaction solution was filtered under reduced pressure, residue was washed with diethyl ether twice to afford 6.5g (78% yield) of Compound 2 as a pale yellow powder. |
78% | With methanol; ammonia; at 10℃; for 1h; | Chloro-7-methoxyquinazolin-6-yl acetate (Compound 1) was placed in a 250 mL three-necked round bottom flask, 100 mL of 7 M NH3-methanol solution was added dropwise with stirring under ice-30 minutes after the drop finished. Below 10 , the reaction was stirred for more than 30min. The reaction solution was filtered under reduced pressure, and the residue was washed twice with diethyl ether to give 6.5 g (yield 78%) of Compound 2 as a pale yellow powder. |
67.8% | With ammonia; In methanol; at 10℃; for 1h; | Example 1 (4S)-4- ({4-[(3-Chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}oxy)-N- cyclopropyl-1-methyl-D-prolinamide Example 1 HATU (0.23g) was added to an agitated solution of (4Y)-4- ( {4- [ (3-CHLORO-2- fluorophenyl) AMINO]-7-METHOXYQUINAZOLIN-6-YL} OXY)-1-METHYL-D-PROLINE (7) (0.18g), cyclopropylamine (34.4mg) and DIPEA (156mg) IN METHYLENE CHLORIDE (5M1). After 16hrs the reaction mixture was reduced in vacuo. The residues were re-dissolved in methylene chloride and washed with sodium hydroxide solution (2M) and water. The organic phase was then purified by column chromatography on silica eluting with increasingly polar mixtures of METHANOL/METHYLENE CHLORIDE (0/100-10/90). THE fractions containing the desired product were combined and evaporated to a foam which was triturated with diethylether to give the title compound as a white solid. (0. 15G). LH NMR Spectrum : (DMSO d6) 0.40-0. 48 (m, 2H), 0.57-0. 64 (M, 2H), 2.05-2. 14 (M, 1H), 2.28 (s, 3H), 2.33-2. 45 (M, 1H), 2.48-2. 56 (M, 1H + DMSO), 2. 61-2. 70 (M, 1H), 3.08 (t, 1H), 3.64 (dd, 1H), 3.94 (s, 3H), 5.06 (M, 1H), 7.20 (s, 1H), 7.28 (t, 1H), 7.44-7. 56 (M, 2H), 7.65 (s, 1H), 7.87 (d, 1H), 8.35 (s, 1H), 9.63 (s, 1H); Mass SPECTRUM : (M+H) + 486. 44 The starting material 1, 2-PYRROLIDINEDICARBOXYLIC acid, 4-hydroxy-, 1- (1, 1-DIMETHYLETHYL) 2- methyl ester, (2R, 4R) (2) was prepared as follows: 1- [3- (DIMETHYLAMINO) PROPYL]-3-ETLIYLCARBODIIMIDE hydrochloride (14.73 g) was added to a stirred suspension of 1, 2-PYRROLIDINEDICARBOXYLIC acid, 4-hydroxy-, l- (l, l-dimethylethyl) ester, (2R, 4R) (1) (13.65 g), DIMETHYLAMINOPYRIDINE (21.65 g) and methanol (5.67 g) in methylene chloride (400 ml) and the reaction mixture was stirred at room temperature for 16 hours. The reaction mixture was washed with citric acid (1.0 M), saturated aqueous sodium bicarbonate solution and saturated brine, dried over MgSO4, filtered and evaporated. The residues were then purified by column chromatography on silica eluting with increasingly polar mixtures of METHANOL/METHYLENE chloride (1/99-5/95). The desired product fractions were combined and evaporated to give 1, 2-PYNOLIDINEDICARBOXYLIC acid, 4-hydroxy-, L- (L, L-DIMETHYLETHYL) 2- methyl ester, (2R, 4R) (2) as a white crystalline solid, (5.9 g). 1H NMR Spectrum : (DMSO d6) 1.32 + 1.38 (2s, 9H), 1.76-1. 87 (M, 1H), 2.24-2. 28 (M, 1H), 3.06-3. 15 (M, 1H), 3.42- 3. 51 (m, 1H), 3.60 + 3.63 (2s, 3H), 4.15-4. 24 (M, 2H), 4.92-5. 00 (M, 1H). Starting material 1, 2-Pyrrolidinedicarboxylic acid, 4-hydroxy-1- (1, 1-dimethylethyl) ester, (2R, 4R), (1), (Boc-D-cis-hyp-OH) is commercially available Starting material (3) was prepared as follows: 6-Acetoxy-4-chloro-7-methoxyquinazoline, (Example 25-5 of in W001/66099 ; 10. 0g, 39.6 MMOLE) was added in portions to a stirred 7N methanolic ammonia solution (220 ML) cooled to 10C in an ice/water bath. After stirring for one hour the precipitate was filtered, washed with diethylether and dried thoroughly under high vacuum to give 4-chloro-7- METHOXYQUINAZOLIN-6-OL (3) (5.65g, 67.8%) ; 1H NMR Spectrum : (DMSO d6) 3.96 (s, 3H); 7.25 (s, 1H); 7.31 (s, 1H); 8.68 (s, 1H) ; Mass Spectrum: (M+H) + 211. The starting material (4) was prepared as follows: Di-ethyl azodicarboxylate (5.71g) was added slowly to a stirred suspension of 1,2- PYNOLIDINEDICARBOXYLIC acid, 4-hydroxy-, L- (L, L-DIMETHYLETHYL) 2-methyl ester, (2R, 4R) (2) (5.9g), 4-CHLORO-7-METHOXYQUINAZOLIN-6-OL (3) (4.6g) AND TRIPHENYLPHOSPHINE (8.6g) in methylene chloride (400 ML) at 25C under an atmosphere of nitrogen and the reaction mixture was stirred for 2 hours. The reaction mixture was then evaporated to ½ volume and purified by column chromatography on silica eluting with increasingly polar mixtures of METHANOL/METHYLENE chloride (1/99-3/97). The desired product fractions were combined and evaporated to give 1-tert-butyl 2-methyl (2R, 4S)-4-[(4-chloro-7-methoxyquinazolin-6- yl) oxy] pyrrolidine-1, 2-dicarboxylate (4) as a pale yellow gum. This was used in the preparation of (5) without further purification. The starting material methyl (4S)-4-({4-[(3-CHLORO-2-FLUOROPHENYL) AMINO]-7- METHOXYQUINAZOLIN-6-YL} OXY)-D-PROLINATE HYDROCHLORIDE (5) was prepared as follows: 4. 0M HCl in Dioxane (15 ml) was added to a suspension of 1-tert-butyl 2-methyl (2R, 4S)-4- [(4-chloro-7-methoxyquinazolin-6-yl0 oxy] pyrrolidine-1, 2-dicarboxylate (4) AND 3-CHLORO-2- fluoroaniline (2.89g) in acetonitrile (400 ML) and the reaction mixture was stirred and heated at 70C for 3 hours. The resulting precipitate was filtered hot and washed with acetonitrile and diethylether and dried under vacuum to give methyl (4S)-4- (14- [ (3-CLILORO-2- FLUOROPHENYL) AMINO]-7-METHOXYQUINAZOLIN-6-YL} OXY)-D-PROLINATE HYDROCHLORIDE (S) as an off- white solid, (6. 3G). TH NMR Spectrum : (DMSO D6) 2.46-2. 60 (M, 2H), 3.37-3. 46 (M, 1H), 3.71 (s, 3H), 3.89-3. 98 (m, 4H), 4.53 (t, 1H), 5.42 (M, 1H), 7.29 (t, 1H), 7.38-7. 48 (M, 2H), 7.55 (t, 1H), 8.64 (s, 1H), 8.75 (s, 1H)... |
67.8% | With methanol; ammonia; at 10℃; for 1h; | 6-Acetoxy-4-chloro-7-methoxyquinazoline, (Example 25-5 of in WO01/66099 ; 10. 0g, 39.6 mmole) was added in portions to a stirred 7N methanolic ammonia solution (220 ml) cooled to 10C in an ice/water bath. After stirring for one hour the precipitate was filtered, washed with diethylether and dried thoroughly under high vacuum to give 4-chloro-6- hydroxy-7-methoxyquinazoline (5.65g, 67. 8%) ; 1H NMR Spectrum : (DMSO d6) 3.96 (s, 3H); 7.25 (s, 1H); 7.31 (s, 1H); 8.68 (s, 1H) ; Mass Spectrum: (M+H) + 211 |
67.8% | With methanol; ammonia; at 10℃; for 1h; | Example 1; 4- (3-CHLORO-2-FLUOROANILINO)-6- [1- (HYDROXYACETYL) PIPERIDIN-4-YLOXY]-7- methoxyquinazoline; HATU (28.9 g) was added to a stirred solution of 4- (3-chloro-2-fluoroanilino)-7- METHOXY-6- (PIPERIDIN-4-YLOXY) quinazoline dihydrochloride (30 g), glycolic acid (5.40 g) and di-isopropylethylamine (44.70 ml) in methylene chloride (900 ml). After 1.5 hours the reaction mixture was washed with sodium hydroxide solution (2M), water and saturated brine. The resulting product was then purified by flash chromatography on silica eluting with 3% MeOH/methylene chloride. The fractions containing the desired product were combined and reduced in vacuo to give the title product as a white solid which was recrystallised from acetonitrile (29.6 g); NMR Spectrum : (DMSO d6) 1.65-1. 81 (m, 2H), 1.99-2. 10 (m, 2H), 3.26- 3.34 (m, 1H), 3.37-3. 47 (m, 1H), 3.60-3. 68 (m, 1H), 3.81-3. 89 (m, 1H), 3.95 (s, 3H), 4.14 (d, 2H), 4.50 (t, 1H), 4.78 (m, 1H), 7.25 (s, 1H), 7.30 (t, 1H), 7.46-7. 55 (m, 2H), 7.88 (s, 1H), 8.40 (s, 1H), 9.55 (s, 1H) ; Mass Spectrum: (M+H) + 460.94. THE 4- (3-CHLORO-2-FLUOROANILINO)-7-METHOXY-6- (PIPERIDIN-4-YLOXY) quinazoline dihydrochloride starting material was prepared as follows: 6-Acetoxy-4-chloro-7-methoxyquinazoline, (Example 25-5 in WO01/66099 ; 10. 0G, 39.6 mmole) was added in portions to a stirred 7N methanolic ammonia solution (220 ml) cooled to 10C in an ice/water bath. After stirring for one hour the precipitate was filtered, washed with diethylether and dried thoroughly under high vacuum to give 4-chloro-6- hydroxy-7-methoxyquinazoline (5.65 g, 67.8 %); NMR Spectrum: (DMSO d6) 3.96 (s, 3H); 7.25 (s, 1H); 7.31 (s, 1H); 8.68 (s, 1H); Mass Spectrum : (M+H) + 211 Di-tert-butylazodicarboxylate (9.22 g) in methylene chloride (20 ml) was added slowly to a stirred suspension of 4-chloro-6-hydroxy-7-methoxyquinazoline (5.63 g), 4-hydroxy-1- tert-butoxycarbonylpiperidine (8.06 g) and triphenylphosphine (10.5 g) in methylene chloride (100 ml) at 5C under an atmosphere of nitrogen. The reaction mixture was allowed to warm to room temperature for 16 hours. The reaction mixture was then evaporated under vacuum and adsorbed onto silica and the product was eluted with isohexane/ethyl acetate/triethylamine (75/24/1 followed by 70/29/1). The fractions containing the desired product were combined and evaporated under vacuum to give tert-butyl 4- [ (4-CHLORO-7-METHOXYQUINAZOLIN-6- yl) oxy] piperidine-l-carboxylate as a white solid (10.3 g) ; IH NMR SPECTRUM : (DMSO d6) 1.40 (s, 9H), 1.56-1. 69 (m, 2H), 1.93-2. 04 (m, 2H), 3.20-3. 31 (m, 2H), 3.60-3. 70 (m, 2H), 4.00 (s, 3H), 4. 89 (m, 1H), 7.45 (s, 1H), 7.50 (s, 1H), 8.86 (s, 1H) ; Mass Spectrum : (M+H) + 394. 4. 0M HC1 in Dioxane (4.0 ml) was added to a suspension of tert-butyl 4- [ (4-chloro-7- methoxyquinazolin-6-yl) oxy] PIPERIDINE-1-CARBOXYLATE (2.62 g) and 3-chloro-2-fluoroaniline (1.08 g) in iso-propanol (50 ml). The reaction mixture was stirred and heated at 100C for 2 hours. The yellow precipitate was filtered hot and washed with iso-propanol followed by diethylether and dried under vacuum to give 6- (PIPERIDIN-4-YLOXY)-4- (3-CHLORO-2- fluoroanilino) -7-methoxyquinazoline as a di-hydrochloride salt (2.38 g) ; 1H NMR SPECTRUM (DMSO D6) 1.84-1. 99 (m, 2H), 2.22-2. 33 (m, 2H), 3.12-3. 33 (m, 4H), 4.00 (s, 3H), 5. 08 (m, 1H), 7.34 (t, 1H), 7.40 (s, 1H), 7.50 (t, 1H), 7.62 (t, 1H), 8.80 (s, 1H), 8. 84-8. 94 (m, 2H), 8.99-9. 11 (m, 1H); Mass Spectrum: (M+H) + 403. |
58 - 95% | With ammonia; water; In 1,4-dioxane; at 0 - 20℃; | Step 6. Product step 5 (8.54 mmol) was converted into 4-chloro-7-hydroxy-6-methoxyquinazoline or 4-chloro-6-hydroxy-7-methoxyquinazoline, respectively, (58-95%) by reacting them with thionyl chloride (12 mL) and DMF (0.3 mL) at 85 C. for 1.5 h. Excess thionyl chloride was removed by distillation. Traces of thionyl chloride were removed by aceotropic distillation wit toluene (two times). Alternatively the products step 5 can be converted into the chlorides by reacting them with a mixture of POCl3 and PCl5. The acetyl groups were removed by hydrolysis with ammonium hydroxide (5 mL, 28-30 wt %) in dioxane/water (100 mL/20 mL) at 0 C. to r.t. |
With ammonia; water; In 1,4-dioxane; at 0 - 20℃; | Step 6. Product step 5 (8.54 mmol) was converted into 4-chloro-7-hydroxy-6-methoxyquinazoline or 4-chloro-6-hydroxy-7-methoxyquinazoline, respectively, (58-95%) by reacting them with thionyl chloride (12 mL) and DMF (0.3 mL) at 85 C for 1.5 h. Excess thionyl chloride was removed by distillation. Traces of thionyl chloride were removed by aceotropic distillation wit toluene (two times). Alternatively the products step 5 can be converted into the chlorides by reacting them with a mixture of POCl3 and PCl5. The acetyl groups were removed by hydrolysis with ammonium hydroxide (5 mL, 28-30 wt%) in dioxane / water (100 mL / 20 mL) at 0 C to r.t. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93.7% | With sulfuryl dichloride; In acetonitrile; at 55℃; | 1) exchange resin 12.8g in D301 macroporous weakly basic styrene anion, 6- (2-morpholino-ethoxy) -7-methoxy-3,4-dihydro-quinazolin-4 ketone (31.9g, 100mol), sulfuryl chloride (16.2g, 120mmol) in 100ml acetonitrile were contact reaction, the contact reaction temperature was 55 , after the reaction was quenched with ice-water, extracted with methylene chloride, concentrated under reduced pressure to give 6-acetoxy-4-chloro-7-methoxy-quinazoline of 31.7g, a yield of 93.7percent, a purity of 99.05percent. |
Tags: 230955-75-6 synthesis path| 230955-75-6 SDS| 230955-75-6 COA| 230955-75-6 purity| 230955-75-6 application| 230955-75-6 NMR| 230955-75-6 COA| 230955-75-6 structure
[ 27631-29-4 ]
2,4-Dichloro-6,7-dimethoxyquinazoline
Similarity: 0.82
[ 50377-49-6 ]
4-Chloro-6,7-dimethoxy-2-methylquinazoline
Similarity: 0.81
[ 27631-29-4 ]
2,4-Dichloro-6,7-dimethoxyquinazoline
Similarity: 0.82
[ 50377-49-6 ]
4-Chloro-6,7-dimethoxy-2-methylquinazoline
Similarity: 0.81
[ 884340-91-4 ]
4-Chloro-5,7-dimethoxyquinazoline
Similarity: 0.81
[ 1841081-27-3 ]
Ethyl 2,4-dichloroquinazoline-6-carboxylate
Similarity: 0.74
[ 34632-69-4 ]
Ethyl 4-chloroquinazoline-2-carboxylate
Similarity: 0.69
[ 740081-22-5 ]
4-((3-Chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl acetate
Similarity: 0.65
[ 1036755-95-9 ]
Methyl 2-oxo-1,2-dihydroquinazoline-6-carboxylate
Similarity: 0.63
[ 499195-60-7 ]
Ethyl 4-(2-chloropyrimidin-4-yl)benzoate
Similarity: 0.63
[ 27631-29-4 ]
2,4-Dichloro-6,7-dimethoxyquinazoline
Similarity: 0.82
[ 50377-49-6 ]
4-Chloro-6,7-dimethoxy-2-methylquinazoline
Similarity: 0.81
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :